Remove tag health-data
article thumbnail

Biogen’s Alzheimer’s drug: What’s the price tag on hope?

World of DTC Marketing

The first clinic; trials were everything but encouraging but so much depend ended on this drug’s approval that Biogen returned and recited the data. Too many doctors, the data was still questionable. If the drug is approved you can bet that it’s going to carry a huge price tag.

Drugs 187
article thumbnail

Grand Rounds October 13, 2023: Incorporating Social Determinants of Health Into PCORnet (Keith Marsolo, PhD)

Rethinking Clinical Trials

Speaker Keith Marsolo, PhD Associate Professor Department of Population Health Sciences Duke University School of Medicine Slides Keywords PCORnet, Common Data Model, EHR, Social Determinants of Health Key Points There are many different definitions of social determinants of health. For example, consider food security.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Grand Rounds January 26, 2024: Advancing the Safe, Effective and Equitable Use of AI in Healthcare (Mark Sendak, MD, MPP; Suresh Balu, MD, MBA)

Rethinking Clinical Trials

DIHI approaches this work through four pillars of innovation: implementation and health delivery science, health technology innovation, leadership and workforce development, and best practices development and dissemination. The Health AI Partnership started with 7 organization partners and has expanded to about 20 organizations.

article thumbnail

Grand Rounds Biostatistics Series January 5, 2024: Methods for Handling Missing Data in Cluster Randomized Trials (Rui Wang, PhD; Moderator: Fan Li, PhD)

Rethinking Clinical Trials

For missing completed at random (MCAR) models, the missing process will be independent of all the covariate treatments and outcomes so that the observed data actually represent the underlying population you’re making an inference about. Most of an analysis can proceed using complete data, so this isn’t an issue.

Trials 275
article thumbnail

Grand Rounds Ethics and Regulatory Series November 11, 2022: Data Sharing and Pragmatic Clinical Trials: Law & Ethics Amidst a Changing Policy Landscape (Stephanie Morain, PhD, MPH; Kayte Spector-Bagdady, JD, MBioethics)

Rethinking Clinical Trials

Berman Institute of Bioethics & Johns Hopkins Bloomberg School of Public Health. Ethics, Data Sharing, Pragmatic Clinical Trials. For PCTs, data volume is potentially larger, data may be “about” those beyond patient-subjects (i.e. Kayte Spector-Bagdady, JD, MBioethics. University of Michigan Medical School.

article thumbnail

Pharma running online ads on vaccine misinformation sites

World of DTC Marketing

NewsGuard found that 67% of the COVID misinformation sites had Google advertising tags and 30% had tags from The Trade Desk. An analysis of programmatic advertising data finds a disconnect between those well-intentioned efforts and the programmatic advertising campaigns that those same companies and institutions finance.

article thumbnail

Grand Rounds March 1, 2024: Effect of an Intensive Food-As-Medicine Program on Health and Health Care Use: Evidence from a Randomized Clinical Trial (Joseph Doyle, PhD)

Rethinking Clinical Trials

Food-as-Medicine observational studies have had a large correlation with improved health. Clinic staff included a dietitian, a nurse and a community health worker. Additional data sources came from EHR data, health plan claims, and program participation data including food visits and education.